| [1] Kisselev AF, Goldberg AL. Proteasome inhibitors: from research tools to drug candidates [J]. Chem Biol, 2001, 8: 739–758.
[2] Delcros JG, Floc’h MB, Prigent C, et al. Proteasome inhibitors as therapeutic agents: current and future strategies [J]. Curr Med Chem, 2003, 10: 479–503.
[3] Shipman M, Thorpe HR, Clemens IR. Synthesis of 1, 3, 2-dioxathiolane-4-methylene-2-oxides: potential allene oxide equivalents [J]. Tetrahedron, 1999, 55: 10845–10850.
[4] Kemp SJ, Bao JM, Pedersen SF. Selective inversion of the proximal or distal hydroxyl groups in syn, syn-3-[N-(alkoxycarbonyl)amino] 1, 2-diols via cyclic sulfates [J]. J Org Chem, 1996, 61: 7162–7167.
[5] Rover S, Adams DR, Benardeau A, et al. Identification of 4-methyl-1, 2, 3, 4, 10, 10a-hexahydropyrazino[1, 2–a] indoles as 5-HT2C receptor agonists [J]. Bioorg Med Chem Lett, 2005, 15: 3604–3608.
[6] Luly JR, Dellaria JF, Plattner JJ, et al. A synthesis of protected aminoalkyl epoxides from α-amino acids [J]. J Org Chem, 1987, 52: 1487–1492.
[7] Branalt J, Kvarnstrom I, Classon B, et al. A convenient synthesis of 1-(S)-[1¢-(S)-(t-butyloxycarbonylamino)-2¢- phenylethyl] oxirane. A useful building block in the synthesis of HIV protease inhibitors [J]. Tetrahedron Lett, 1997, 38: 3483–3486.
[8] Ikunaka M, Matsumoto J, Fujima Y, et al. An enantioselective synthesis of (2S, 3R)-3-(N-benzyloxycarbonyl) amino- 1-chloro-4-phenylthiobutan-2-ol, a central intermediate of nelfinavir [J]. Org Process Res Dev, 2002, 6: 49–53. |
>
>